Swiss Society
of Cannabis in Medicine


We support the clinical and basic research for the medicalization of cannabis and cannabinoids.

Data Base

A data base should allow us to evaluate and validate the different treatments, indications and therapy experiences. Consequently, this is the basis for the elaboration of therapy recommendations and guidelines.

Professional Informations and Therapy Recommendations

Evidence- and experience-based therapy recommendations should support health professionals in practice.

Patient Informations

In cooperation with patient organizations we elaborate professional informations for patients and relatives.


We inform about the legal and regulatory situation regarding medical cannabis and cannabinoids, in particular the planned revision of the Swiss narcotic law and newly approved appropriate preparations.


Cannabinoid Conference 2022
SSCM-IACM Joint Conference 2022
Congress Center Basel
20-21 October 2022
Credits: FPH 100 points, SPS 6 points
Proceedings (poster and lecture abstracts): see conference website


We are active in the education of health professionals, patients and other interested people, aiming to most efficiently and safely use cannabis and cannabinoids in medicine.

Scientific Journals

«Medical Cannabis and Cannabinoids» is the scientific journal of SGCM-SSCM. It is published by Karger in Basel allowing open access. The peer-reviewed journal offers an international forum for the presentation and discussion of research results covering the rapidly developing use of cannabis and cannabinoids in medicine.